Insilico Medicine Celebrates Its 10th AI-Driven Drug Candidate to Get FDA IND Clearance
Insilico Medicine has announced FDA IND clearance for ISM5939, marking the 10th AI-designed drug candidate from the company to enter …
All Posts
Brainomix Wins Two Awards for AI Imaging Technology
Brainomix has been named the LSX European Lifestars “Healthtech Company of the Year” and the OBN “Most Transformative Healthtech Company …
Raidium Secures €16 Million to Advance Radiology Foundation Model
Raidium, a french start-up building a radiology-focused artificial intelligence, has raised €16 million in seed funding co-led by Newfund and …
Wyss Institute’s iNodes Team Secures ARPA-H Award to Advance Implantable Immune Organs for Ovarian Cancer Treatment
The Wyss Institute at Harvard University has received an ARPA-H Sprint for Women’s Health award to advance iNodes, an innovative …
Jimini Health Launches with $8M Seed Funding to Advance Mental Health Care
Stanford-based Jimini Health, a mental health startup founded in 2023, has announced its official launch with $8 million in seed …
Axsome Therapeutics Announces Positive Phase 3 Results for Reboxetine in Narcolepsy
Axsome Therapeutics announced that its investigational treatment, AXS-12 (reboxetine), met the primary endpoint in the ENCORE Phase 3 trial. The …
Novo Holdings Supports $135 Million Funding to Advance Adcendo’s Antibody-Drug Conjugate Development
Novo Holdings has joined a $135 million Series B financing round for Adcendo, a clinical-stage biotechnology company headquartered in Copenhagen, …
Valence Labs and Recursion Launch OpenQDC: The Largest Public Quantum Mechanical Dataset for ML Research
Researchers at Valence Labs, powered by Recursion, have introduced OpenQDC (Open Quantum Data Commons), an extensive, publicly accessible quantum mechanical …
Roche Expands Cell Therapy Portfolio with $1.5 Billion Poseida Therapeutics Acquisition
Swiss pharmaceutical giant Roche has announced its acquisition of Poseida Therapeutics, a San Diego-based biotech company specializing in next-generation cell …
A New Genetic Insight into Mitochondrial DNA Depletion Syndrome
Japanese researchers have identified a novel genetic cause for hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), linking it to variants in …
Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials
Today, we’re diving into the results of Advarra’s 2024 Site-Sponsor-CRO Collaboration Survey, which highlights three major barriers hindering collaboration in …
M42 CEO Hasan Jasem Al Nowais Calls for a Global Shift Toward Preventative Healthcare
At the 7th Annual Longevity Forum in London, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, delivered …